Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt RepaymentsMachine, Furnitures, Fixtures & OtherOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Shares IssuedShares Outstanding
Ratios

Fortress Biotech (FBIO) R&D In Process (2016 - 2023)

Historic R&D In Process for Fortress Biotech (FBIO) over the last 10 years, with Q4 2023 value amounting to $31000.0.

  • Fortress Biotech's R&D In Process fell 9524.54% to $31000.0 in Q4 2023 from the same period last year, while for Dec 2023 it was $4.3 million, marking a year-over-year increase of 48432.43%. This contributed to the annual value of $300000.0 for FY2024, which is 9306.2% down from last year.
  • According to the latest figures from Q4 2023, Fortress Biotech's R&D In Process is $31000.0, which was down 9524.54% from $60000.0 recorded in Q3 2023.
  • In the past 5 years, Fortress Biotech's R&D In Process registered a high of $14.9 million during Q1 2020, and its lowest value of $1000.0 during Q2 2022.
  • Moreover, its 5-year median value for R&D In Process was $454000.0 (2019), whereas its average is $2.2 million.
  • Its R&D In Process has fluctuated over the past 5 years, first surged by 320377.78% in 2020, then tumbled by 9999.09% in 2022.
  • Quarter analysis of 5 years shows Fortress Biotech's R&D In Process stood at $450000.0 in 2019, then rose by 23.56% to $556000.0 in 2020, then tumbled by 92.81% to $40000.0 in 2021, then surged by 1530.0% to $652000.0 in 2022, then crashed by 95.25% to $31000.0 in 2023.
  • Its last three reported values are $31000.0 in Q4 2023, $60000.0 for Q3 2023, and $3000.0 during Q2 2023.